- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06365476
Studio FlexWave: efficacia della terapia extracorporea con onde d'urto nella spasticità degli arti superiori post-ictus
Effetti dell'onda d'urto extracorporea sulla spasticità dei flessori degli arti superiori nei pazienti con ictus: uno studio controllato randomizzato
Extracorporeal shock wave therapy (ESWT) has emerged as an effective therapeutic intervention for addressing post-stroke limb spasticity. This research aims to explore the therapeutic implications of focused ESWT for wrist and finger flexor muscles in patients suffering from post-stroke upper limb spasticity.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This study aimed to evaluate the effects of focused Extracorporeal Shock Wave Therapy (ESWT) on upper limb flexor spasticity in stroke patients. Participants were randomized into two groups: an experimental group receiving targeted ESWT on specific forearm flexor muscles, and a control group receiving placebo treatments mimicking the shockwave therapy, with treatments administered twice weekly over two weeks for a total of four sessions.
The efficacy of the treatment was measured using a comprehensive set of assessment tools, including range of motion, hand grip strength, pain levels, spasticity scales, functional assessments, as well as measures of daily living activities, ultrasound strain elastography. The outcomes were evaluated at multiple points in time: before treatment, and 1, 4, 12, and 24 weeks after the therapy concluded, to assess both immediate and sustained effects of the treatment on upper limb function and spasticity in stroke survivors.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Taipei, Taiwan, 100
- Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Individuals aged 18 years or older with unilateral cerebral stroke.
- Wrist/finger flexor muscle tone with a score greater than 1 on the Modified Ashworth Scale.
- Stable medical condition and vital signs.
- Conscious and able to comply with instructions.
Exclusion Criteria:
- History of more than one stroke, traumatic brain injury, or cerebral neoplasm.
- Coexisting central nervous system disorders (e.g., spinal cord injury, Parkinson's disease) or other musculoskeletal diseases affecting muscle tone assessment.
- Contraindications for shockwave intervention, such as malignancies, coagulopathies, local infections, or use of cardiac pacemakers.
- Undergone shockwave therapy or botulinum toxin injections for post-stroke spasticity in the past three months.
- Cognitive, consciousness, or language impairments preventing participation in the intervention or functional assessments.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Triplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Focused Extracorporeal Shock Wave Therapy
Participants in this arm will receive focused Extracorporeal Shock Wave Therapy (ESWT) targeting three specific muscles: the flexor carpi ulnaris, flexor carpi radialis, and flexor digitorum superficialis. Each muscle will receive 1,500 shockwave shots per session, accumulating to a total of 4,500 shots across all targeted muscles in each session. The treatment will be administered twice a week for two consecutive weeks, resulting in a total of four treatment sessions. |
The focused shockwaves are directed at the affected muscles in the upper limb, specifically targeting the flexor carpi ulnaris, flexor carpi radialis, and flexor digitorum superficialis. |
|
Comparatore placebo: Placebo-Controlled Shockwave Therapy
Participants in this arm will receive placebo-controlled focused ESWT, mirroring the treatment protocol of the experimental group but without the application of active shockwaves. |
The focused shockwaves are directed at the affected muscles in the upper limb, specifically targeting the flexor carpi ulnaris, flexor carpi radialis, and flexor digitorum superficialis. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
modified Ashworth scale (MAS)
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
Evaluate spasticity in individuals with neurological conditions. The scale ranges from 0, indicating no increase in muscle tone, to 4, which represents severe spasticity with affected parts rigid in flexion or extension. |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
modified Tardieu scale (MTS) R2-R1 Angle
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
Difference between passive range of motion (R2) and the angle of muscle catch (R1), measured in degrees. Larger values indicate greater dynamic spasticity. |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
Tardieu grade
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
Spasticity severity (0-5); higher grades indicate greater spasticity. |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
passive range of motion for the wrist and finger joints
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
the extent to which a joint can be moved without the patient actively participating in the movement |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
Medical Research Council (MRC) scale
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
grades voluntary muscle strength on a 0-5 ordinal scale |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
hand grip strength
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
use dynamometer to record the maximum force applied when the patient squeezes it |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
Barthel index
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
measures a person's daily living abilities, focusing on ten areas of self-care and mobility. Scores range from 0 to 100, with higher scores denoting greater independence. |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
Functional Independence Measure (FIM)
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
assesses a patient's level of disability and tracks changes over time, with a focus on physical and cognitive functioning across 18 items, scored from 18 (total assistance required) to 126 (fully independent). |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
Wolf Motor Function Test (WMFT) Functional ability score
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
assess upper extremity function in individuals with neurological impairments, using 15 functional tasks. Scoring is on a 6-point ordinal scale, ranging from 0 ("Does not attempt with upper extremity being tested," indicating severe impairment) to 5 ("Movement appears to be normal," suggesting full functionality). Lower scores indicate greater impairment. |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
Action Research Arm Test (ARAT)
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
a standardized measure evaluating upper limb motor ability in stroke patients, scoring from 0 (no movement) to 57 (normal arm function). It assesses grasp, grip, pinch, and gross arm movement. |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
Fugl-Meyer Assessment for the Upper Extremity (FMA-UE)
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
range from 0 (complete paralysis) to 66 (full function), assessing motor recovery in post-stroke upper extremities |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
|
ultrasound assessment
Lasso di tempo: pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
used strain elastography to assess elasticity of forearm muscles |
pre-treatment; 1, 4, 12, and 24 weeks post-treatment
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Shu-mei Yang, MD, National Taiwan University Hospital
Pubblicazioni e link utili
Pubblicazioni generali
- Dymarek R, Taradaj J, Rosinczuk J. Extracorporeal Shock Wave Stimulation as Alternative Treatment Modality for Wrist and Fingers Spasticity in Poststroke Patients: A Prospective, Open-Label, Preliminary Clinical Trial. Evid Based Complement Alternat Med. 2016;2016:4648101. doi: 10.1155/2016/4648101. Epub 2016 Jul 18.
- Cabanas-Valdes R, Calvo-Sanz J, Urrutia G, Serra-Llobet P, Perez-Bellmunt A, German-Romero A. The effectiveness of extracorporeal shock wave therapy to reduce lower limb spasticity in stroke patients: a systematic review and meta-analysis. Top Stroke Rehabil. 2020 Mar;27(2):137-157. doi: 10.1080/10749357.2019.1654242. Epub 2019 Nov 11.
- Yasar E, Adiguzel E, Kesikburun S, Yenihayat I, Yilmaz B, Alaca R, Tan AK. Assessment of forearm muscle spasticity with sonoelastography in patients with stroke. Br J Radiol. 2016 Dec;89(1068):20160603. doi: 10.1259/bjr.20160603. Epub 2016 Oct 25.
- Jia G, Ma J, Wang S, Wu D, Tan B, Yin Y, Jia L, Cheng L. Long-term Effects of Extracorporeal Shock Wave Therapy on Poststroke Spasticity: A Meta-analysis of Randomized Controlled Trials. J Stroke Cerebrovasc Dis. 2020 Mar;29(3):104591. doi: 10.1016/j.jstrokecerebrovasdis.2019.104591. Epub 2019 Dec 31.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Manifestazioni neurologiche
- Malattie muscoloscheletriche
- Disturbi cerebrovascolari
- Malattie del cervello
- Malattie del sistema nervoso centrale
- Malattie del sistema nervoso
- Malattie vascolari
- Malattia cardiovascolare
- Malattie muscolari
- Ipertono muscolare
- Manifestazioni neuromuscolari
- Condizioni patologiche, segni e sintomi
- Segni e sintomi
- Spasticità muscolare
- Ictus
- Terapie
- Modalità di terapia fisica
- Riabilitazione
- Terapia ultrasonica
- Diatermia
- Ipertermia, indotta
- Terapia extracorporeal shockwave
Altri numeri di identificazione dello studio
- 202309126RIND
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .